Your browser doesn't support javascript.
loading
A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.
Posey, James A; Khazaeli, Mohammad B; Bookman, Michael A; Nowrouzi, Anahit; Grizzle, William E; Thornton, Jennifer; Carey, Delicia E; Lorenz, Jennifer M; Sing, Amy P; Siegall, Clay B; LoBuglio, Albert F; Saleh, Mansoor N.
Affiliation
  • Posey JA; Departments of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-3300, USA. James.Posey@cc.uab.edu
Clin Cancer Res ; 8(10): 3092-9, 2002 Oct.
Article in En | MEDLINE | ID: mdl-12374676
Search on Google
Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunotoxins / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2002 Type: Article
Search on Google
Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunotoxins / Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2002 Type: Article